Completed PHASE3 INTERVENTIONAL 2-arm NCT02709564

Sublingual Misoprostol in Decreasing Blood Loss Prior to Myomectomy (SL-MISO)

Single Dose Versus Two Doses of Sublingual Misoprostol in Decreasing Blood Loss Prior to Abdominal Myomectomy: A Randomized Double-blinded Clinical Trial

Sponsor: Assiut University

Conditions Blood Loss in Myomectomy

Interventions Misoprostol 400 sublingual placebo 400 sublingual

Updated 9 times since 2017 Last updated: May 6, 2020 Started: Dec 31, 2016 Primary completion: Dec 31, 2019 Completion: Feb 29, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Blood Loss in Myomectomy and is currently completed. Assiut University leads this study, which shows 9 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2020 — Jan 2021 [monthly]

Completed PHASE3

Status: Recruiting → Completed
Aug 2018 — Jun 2020 [monthly]

Recruiting PHASE3

▶ Show 4 earlier versions

Jun 2018 — Aug 2018 [monthly]

Recruiting PHASE3
Apr 2017 — Jun 2018 [monthly]

Recruiting PHASE3
Feb 2017 — Apr 2017 [monthly]

Recruiting PHASE3
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE3

First recorded

Dec 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assiut University

Data source: Assiut University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Assiut, Egypt